Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017

【24h】

Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017

机译：价格的趋势值和生命的意义获得了在新批准1995年癌症治疗到2017年

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The prices of newly approved cancer drugs have risen over the past decades. A key policy question is whether the clinical gains offered by these drugs in treating specific cancer indications justify the price increases.

机译：背景:新批准的价格癌症药物已在过去的几十年。政策问题是临床收益提供的这些药物在治疗具体癌症迹象证明价格上涨。

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 》 |2019年第12期| 1387-1395| 共9页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Antineoplastic Agents; Median; cancer therapySurvivalPrices;

机译：抗肿瘤药制剂;中等;癌症;

相似文献

外文文献
中文文献

1. First Carbon Ion Cancer Therapy Facility of China Approved by NMPA [J] . Wang Kun, Technology TransferIndustrialization office 中国科学院近代物理研究所和兰州重离子研究装置年报：英文版 . 2019 ,第001期
2. Near-Dead Cells to Special Tetraploidy to First Cells to Cancer Diagnostic Morphology: Unlikely Therapy-Gain from For-Profit Industrial Goliath [J] . Kirsten H. Walen 癌症治疗（英文） . 2020 ,第007期
3. CHIC2017:Integrating industry resources and gaining insights into industry trends [J] . 中国纺织（英文版） . 2017 ,第1期
4. Crafts and Creative Media in Therapy (2017), by Carol Crellin Tubbs & Margaret Drake, 310 pp. Soft Cover, ISBN: 978-1630911096, SLACK Incorporated, Thorofare, NJ, Price: $54.16 [J] . Virginia Chu Occupational therapy in health care . 2017 ,第1a4期

机译：Crafts和Creative Media in Therapy（2017），Carol Crellin Tubbs和Margaret Drake，310 pp。软封面，ISBN：978-1630911096，Lack Incloodated，Thorofare，NJ，Price：$ 54.16

Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017

摘要

著录项

相似文献

相关主题

期刊订阅